IRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
The Analyst Verdict: IRhythm Technologies In The Eyes Of 5 Experts
Truist Financial Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Announces Target Price $134
IRhythm Technologies Price Target Cut to $134.00/Share From $145.00 by Truist Securities
IRhythm Technologies Is Maintained at Buy by Truist Securities
Truist Lowers Price Target on IRhythm Technologies to $134 From $145, Maintains Buy Rating
Express News | IRhythm Technologies Inc : Truist Securities Cuts Target Price to $134 From $145
IRhythm Technologies Price Target Cut to $130.00/Share From $135.00 by Morgan Stanley
IRhythm Technologies Is Maintained at Overweight by Morgan Stanley
Express News | IRhythm Tech Inc : Morgan Stanley Cuts Target Price to $130.00 From $135.00
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $130
Morgan Stanley Cuts Price Target on IRhythm Technologies to $130 From $135, Keeps Overweight Rating
Oppenheimer's Top SMID Ideas Within High-growth Themes
Despite Currently Being Unprofitable, IRhythm Technologies (NASDAQ:IRTC) Has Delivered a 57% Return to Shareholders Over 3 Years
Did Your Heart Skip a Beat? Your Wearable Knows. -- Barrons.com
Heart Just Skip a Beat? Your Watch Already Knows.
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
Street Calls of the Week: Micron Downgrade, Upgrade for Kroger
IRhythm Gains as Wolfe Upgrades on Valuation